BORGHETTI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 4.534
AS - Asia 1.982
EU - Europa 1.962
SA - Sud America 328
Continente sconosciuto - Info sul continente non disponibili 147
AF - Africa 54
OC - Oceania 9
Totale 9.016
Nazione #
US - Stati Uniti d'America 4.394
SG - Singapore 683
IT - Italia 652
CN - Cina 578
DE - Germania 272
BR - Brasile 263
HK - Hong Kong 197
UA - Ucraina 181
PL - Polonia 153
VN - Vietnam 149
FI - Finlandia 136
FR - Francia 121
BD - Bangladesh 115
GB - Regno Unito 104
RU - Federazione Russa 84
TR - Turchia 77
NL - Olanda 59
CA - Canada 56
IN - India 56
IE - Irlanda 55
CZ - Repubblica Ceca 27
MX - Messico 23
AR - Argentina 21
ES - Italia 21
ID - Indonesia 21
ZA - Sudafrica 19
SE - Svezia 17
JP - Giappone 16
LT - Lituania 14
CO - Colombia 13
PK - Pakistan 13
EC - Ecuador 11
IQ - Iraq 11
CR - Costa Rica 10
TT - Trinidad e Tobago 10
AT - Austria 9
BE - Belgio 9
IL - Israele 9
EG - Egitto 8
MA - Marocco 8
SV - El Salvador 8
AU - Australia 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
EU - Europa 6
PH - Filippine 6
PR - Porto Rico 6
VE - Venezuela 6
BY - Bielorussia 5
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
JM - Giamaica 5
UZ - Uzbekistan 5
BO - Bolivia 4
BZ - Belize 4
GT - Guatemala 4
HU - Ungheria 4
MK - Macedonia 4
MY - Malesia 4
NI - Nicaragua 4
TN - Tunisia 4
UG - Uganda 4
AZ - Azerbaigian 3
DK - Danimarca 3
GP - Guadalupe 3
HN - Honduras 3
KZ - Kazakistan 3
NP - Nepal 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CL - Cile 2
ET - Etiopia 2
IR - Iran 2
IS - Islanda 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
LB - Libano 2
NG - Nigeria 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AO - Angola 1
BB - Barbados 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
FJ - Figi 1
GY - Guiana 1
HR - Croazia 1
HT - Haiti 1
KH - Cambogia 1
Totale 8.867
Città #
Ashburn 545
Singapore 386
Fairfield 315
San Jose 277
Chandler 198
Hong Kong 195
Woodbridge 180
Houston 179
Seattle 167
Council Bluffs 145
New York 145
Warsaw 145
Jacksonville 139
Cambridge 126
Beijing 124
Wilmington 115
Los Angeles 109
Helsinki 103
Dearborn 93
The Dalles 89
Munich 87
Princeton 84
Dallas 82
Ann Arbor 63
Milan 63
Brescia 62
Istanbul 55
Ho Chi Minh City 53
Dublin 52
Lauterbourg 51
Santa Clara 49
Des Moines 39
Nanjing 39
Shanghai 35
Columbus 30
São Paulo 30
Buffalo 29
Moscow 26
North Bergen 25
San Francisco 25
Dong Ket 24
San Diego 24
Denver 23
Phoenix 23
Redondo Beach 23
Chicago 22
London 22
Washington 22
Atlanta 20
Boardman 20
Hanoi 20
Rome 20
Turku 20
Brooklyn 19
Chennai 19
Orem 19
Brno 16
Changsha 16
Montreal 15
Nanchang 15
Tokyo 15
Frankfurt am Main 13
Johannesburg 13
Jakarta 12
Newark 12
Poplar 12
Shenyang 12
Hebei 11
Paris 11
Bologna 10
Florence 10
Jinan 10
Turin 10
Zhengzhou 10
Amsterdam 9
Charlotte 9
Kunming 9
Mexico City 9
Nuremberg 9
Tianjin 9
Toronto 9
Ankara 8
Brasília 8
Brussels 8
Düsseldorf 8
Guangzhou 8
Manchester 8
Naples 8
Rio de Janeiro 8
Romola 8
San José 8
Boston 7
Catania 7
Da Nang 7
Philadelphia 7
San Salvador 7
Stockholm 7
Bari 6
Bergamo 6
Cairo 6
Totale 5.520
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 518
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 282
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 245
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 237
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 227
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 218
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 216
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 201
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 195
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 189
From Molecular to Clinical Radiation Biology of Glioblastoma 186
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 186
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 186
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 185
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 182
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 179
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 179
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 175
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 175
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 174
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 173
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 170
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 157
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 156
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 154
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 153
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 151
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 151
Current radiotherapy techniques in NSCLC: challenges and potential solutions 150
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 148
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 141
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 138
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 137
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 134
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 128
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 126
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 123
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 122
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 121
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter Study 116
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer 114
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 112
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 110
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 108
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 105
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience 101
Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer 99
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 96
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 96
Letter to the Editor 96
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 95
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 93
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 91
Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort 90
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 84
Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the 'radio talk' webinars 80
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 71
What Have You Been Told? Awareness of Prognosis of Patients in an Italian Home Palliative Care Service 63
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 58
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO) 51
null 13
Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study 6
Totale 9.016
Categoria #
all - tutte 43.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022341 0 0 0 0 27 31 26 34 27 47 24 125
2022/2023514 55 18 24 36 51 105 5 69 96 6 31 18
2023/2024775 29 16 94 45 45 179 35 47 102 41 36 106
2024/20251.337 28 40 26 195 100 139 89 73 147 119 234 147
2025/20262.911 265 284 196 398 330 217 380 90 216 245 165 125
2026/2027826 102 121 163 400 40 0 0 0 0 0 0 0
Totale 9.016